VYNE compared with RLYB: revenue, margins and what each company keeps, and the suppliers and customers both name

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

RLYBRallybio Corp

Mkt capRevenueRevenue

Compare

VYNEVYNE Therapeutics Inc.

RLYBRallybio Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VYNE

Reportimpliedrealized× implied

Aug 14 '26—▼−0.54%—

Jul 29 '26—▲+8.56%—

Nov 6 '25—▲+4.59%—

Aug 14 '25—▲+0.69%—

RLYB

No earnings history for RLYB.

= impliedVYNE realized, solidRLYB realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

VYNEVYNE Therapeutics Inc.

15.49▲+13.93%· post 15.50

Mkt cap—Revenue—Revenue—

RLYBRallybio Corp

16.08▲+2.49%· post 15.69

ClosedNov 6 '26

Mkt cap$84.8MRevenue$212,000Q1 FY26Revenue$858,000FY25

Compare

ClosedNov 6 '26

VYNEVYNE Therapeutics Inc.

RLYBRallybio Corp

15.49▲+13.93%post 15.50

Price

16.08▲+2.49%post 15.69

—

Mkt cap

$84.8M

—

Revenue

$212,000Q1 FY26

—

Revenue

$858,000FY25

VYNE15.49▲+13.93%vsRLYB16.08▲+2.49%ClosedNov 6 '26